cyramza 500mg injection - Ramucirumab (500mg) medicine

Cyramza 500mg Injection (ramucirumab): Comprehensive Medicine Guide

No reviews yet
🏭 Eli Lilly and Company India Pvt Ltd 📦 Varies by brand 💊 Allopathy 📅 Updated: Nov 21, 2026
⚠️ Hepatotoxicity Risk 🤰 Pregnancy Category This medicine can cause fetal harm when administered to a pregnant woman. Based on its mechanism of action, it may cause fetal harm. Women of childbearing potential should use effective contraception during treatment and for at least 3 months after the last dose. 📋 Prescription Required 💊 Generic Available
Medically Reviewed
12 min read
Evidence: High
Dr. Ravishankar Kumar
Medically Reviewed by Dr. Ravishankar Kumar ✓ Verified Doctor
B.A.M.S. (RMLAU Ayodhya) • Ex-Balrampur Hospital, Lucknow
Dr. Ravishankar Kumar
Clinically Verified by Dr. Ravishankar Kumar (B.A.M.S., RMLAU) — View Medical Verification Profile ↗
Clinical Background: Balrampur Hospital, Lucknow (Emergency Medicine) & SCPM Hospital | Standards: CDSCO, Indian Pharmacopoeia (IP) & WHO

When to Call Your Doctor IMMEDIATELY

  • Blood in vomit or black, tarry stools
  • Severe headache with confusion or vision changes
  • Chest pain, shortness of breath, or sudden weakness
  • Severe abdominal pain with fever
  • Swelling of face, lips, or throat during infusion
  • Unusual bruising or bleeding from gums or nose
  • Decreased urine output or swelling in legs

If experiencing severe symptoms, call emergency services immediately.

What is cyramza 500mg injection used for?

This medicine is a targeted cancer therapy given by intravenous infusion. It works by blocking VEGFR-2 to inhibit blood vessel growth in tumors. It is used for advanced gastric, colorectal, liver, and lung cancers.

  • Generic Name: Ramucirumab
  • Manufacturer: Eli Lilly and Company India Pvt Ltd
  • Form: Allopathy
  • Pregnancy Category: Consult doctor
  • Prescription Required: Yes

🇮🇳 cyramza 500mg injection के बारे में (Hindi Summary)

उपयोग: यह दवा रामुसिरुमैब 500 मिलीग्राम इंजेक्शन के रूप में एक प्रिस्क्रिप्शन-आधारित कैंसर रोधी दवा है। यह मुख्य रूप से पेट के कैंसर, कोलोरेक्टल कैंसर, लीवर कैंसर और फेफड़ों के कैंसर के इलाज के लिए दी जाती है। यह दवा ट्यूमर को खून की आपूर्ति करने वाली नई रक्त वाहिकाओं के निर्माण को रोकती है, जिससे ट्यूमर की वृद्धि धीमी हो जाती है। यह दवा केवल अस्पताल में डॉक्टर या नर्स द्वारा नस के माध्यम से दी जाती है। इसे हर दो या तीन सप्ताह में एक बार दिया जाता है। यह दवा गर्भवती महिलाओं के लिए नहीं है क्योंकि यह भ्रूण को नुकसान पहुंचा सकती है।

साइड इफेक्ट्स: इस दवा के सामान्य दुष्प्रभावों में उच्च रक्तचाप, दस्त, थकान, सिरदर्द और सफेद रक्त कोशिकाओं की कमी शामिल हैं। कुछ रोगियों को मुंह के छाले, पेट दर्द, मतली या दाने हो सकते हैं। गंभीर दुष्प्रभावों में गंभीर रक्तस्राव, रक्त के थक्के, स्ट्रोक, दिल का दौरा और गंभीर उच्च रक्तचाप शामिल हो सकते हैं। यदि आपको असामान्य रक्तस्राव, गंभीर सिरदर्द, सीने में दर्द या सूजन दिखाई दे तो तुरंत डॉक्टर को बताएं।

सुरक्षा सलाह: यह दवा केवल योग्य स्वास्थ्य पेशेवर द्वारा अस्पताल में दी जानी चाहिए। उपचार के दौरान नियमित रूप से रक्तचाप की जांच करवाएं। गर्भवती महिलाओं को यह दवा नहीं लेनी चाहिए। उपचार के दौरान और अंतिम खुराक के कम से कम तीन महीने बाद तक गर्भधारण से बचें। स्तनपान कराने वाली महिलाओं को यह दवा नहीं लेनी चाहिए। यदि आपको रक्तस्राव, चक्कर आना या सांस लेने में कठिनाई हो तो तुरंत डॉक्टर से संपर्क करें।

💡 Did You Know? Over 80% of the antiretroviral drugs used globally to combat AIDS are supplied by Indian pharmaceutical companies.

cyramza 500mg injection Uses & Benefits

Gastric or gastroesophageal junction adenocarcinoma Well-established

Used as a single agent or in combination with paclitaxel for advanced or metastatic disease after prior chemotherapy.

Metastatic colorectal cancer Well-established

Used in combination with FOLFIRI chemotherapy for patients whose disease has progressed on prior treatment.

Hepatocellular carcinoma Well-established

Used as a single agent for patients with advanced liver cancer who have elevated alpha-fetoprotein and have been treated with sorafenib.

Non-small cell lung cancer Well-established

Used in combination with docetaxel for metastatic disease after platinum-based chemotherapy.

Off-Label & Investigational Uses:

Other solid tumors Limited (Off-label)

Occasionally used in clinical trials for other advanced solid tumors, but not approved for routine use.

Primary Treatment for: Gastric or gastroesophageal junction adenocarcinoma
Also Treats:
Metastatic colorectal cancer Hepatocellular carcinoma Non-small cell lung cancer

📋 Drug Information

Generic Name(s)Ramucirumab
Brand NameCyramza
ManufacturerEli Lilly and Company India Pvt Ltd
Packaging / FormVaries by brand (Allopathy)
Therapeutic ClassANTI NEOPLASTICS
Action ClassVascular endothelial growth factor (VEGF) inhibitor
Route of AdministrationIntravenous infusion
StorageStore vials in a refrigerator at 2°C to 8°C. Do not freeze. Keep vials in the original carton to protect from light. Do not shake.
Shelf LifeNot established from the available information.
WHO GuidelineNot established from the available information.
ICMR GuidelineNot established from the available information.

👨‍⚕️ Doctor's Practical Tips

Evidence-based practical advice from experienced clinicians

1
Monitor blood pressure before every infusion and regularly during treatment.
2
Check urine protein before each dose to detect proteinuria early.
3
Premedicate with an antihistamine to reduce infusion-related reactions.
4
Assess for bleeding risk and avoid concurrent anticoagulants if possible.
5
Educate patients on recognizing signs of thromboembolic events and when to seek help.
6
Consider dose interruption or discontinuation if severe hypertension or bleeding occurs.

🔍 Is This Medicine Right for Your Symptom?

Educational reference. Always consult a doctor for diagnosis.

✅
Advanced gastric cancer
This medicine is approved for this condition.
Likely Use
✅
Metastatic colorectal cancer
This medicine is approved for this condition.
Likely Use
✅
Hepatocellular carcinoma
This medicine is approved for this condition.
Likely Use
✅
Non-small cell lung cancer
This medicine is approved for this condition.
Likely Use
❌
Common cold
This medicine is not used for infections.
Not Primary

🔬 How This Medicine Works (Pharmacology)

Pharmacokinetics

AbsorptionThis medicine is administered intravenously, so absorption from the gastrointestinal tract does not apply. It is directly delivered into the bloodstream.
DistributionNot established from the available information.
Protein BindingNot established from the available information.
MetabolismNot established from the available information.
Half-LifeNot established from the available information.
ExcretionNot established from the available information.
BioavailabilityNot applicable because this medicine is given intravenously, providing 100% bioavailability.
Onset of ActionNot established from the available information.
Peak Plasma TimeNot established from the available information.
Duration of ActionNot established from the available information.

How It Works

This medicine is a recombinant human monoclonal antibody that binds with high affinity to the extracellular domain of vascular endothelial growth factor receptor 2 (VEGFR-2). By binding to VEGFR-2, it blocks the interaction of VEGF-A, VEGF-C, and VEGF-D with the receptor. This prevents receptor activation and inhibits downstream signaling pathways that promote endothelial cell proliferation, migration, and survival. As a result, the formation of new blood vessels that supply the tumor is reduced, which can slow tumor growth and progression.

Mechanism Steps

1
Binding to VEGFR-2: This medicine binds specifically to the extracellular portion of VEGFR-2 on endothelial cells.
2
Blockade of VEGF ligands: The binding prevents VEGF-A, VEGF-C, and VEGF-D from activating the receptor.
3
Inhibition of receptor phosphorylation: Without ligand binding, the receptor does not undergo autophosphorylation and downstream signaling is halted.
4
Reduced angiogenesis: This leads to decreased endothelial cell proliferation, migration, and survival, resulting in reduced new blood vessel formation.
5
Tumor growth suppression: The tumor receives less blood supply and nutrients, which slows its growth and may lead to tumor shrinkage.

💡 How to Take cyramza 500mg injection

Strength: 500 mg/50 mL (10 mg/mL) single-use vial for intravenous infusion

1This medicine is given by a healthcare professional as an intravenous infusion.
2The infusion is typically given over 60 minutes.
3Premedication with an antihistamine may be given 30-60 minutes before infusion.
4Vital signs are monitored before, during, and after the infusion.
5Report any discomfort or unusual symptoms to the nurse immediately.

Dosage Information

Adult DosageThe usual adult dose of this medicine is 8 mg per kilogram of body weight given as an intravenous infusion every two weeks. For some indications, a flat dose of 10 mg per kilogram may be used. The infusion is typically given over 60 minutes. Dose must be individualized by a qualified clinician based on indication, patient weight, and tolerability. Premedication with an antihistamine may be given before infusion to reduce infusion-related reactions.
Pediatric DosagePediatric dosing is not established from available information. Consult a pediatric oncologist.
Elderly DosageNo specific dose adjustment is recommended for elderly patients based on age alone. However, elderly patients may be more sensitive to side effects such as hypertension and thromboembolic events. Monitor closely.
Renal ImpairmentNo dose adjustment is recommended for patients with renal impairment. However, monitor for proteinuria and worsening renal function.
Hepatic ImpairmentNo dose adjustment is recommended for patients with mild to moderate hepatic impairment. Safety and efficacy have not been established in patients with severe hepatic impairment.
Maximum Daily DoseNot applicable as this medicine is given as a single infusion every 2 or 3 weeks. The maximum single dose is 10 mg/kg.

Dosage Timeline

🌅 Morning ❌ ☀️ Afternoon ❌ 🌆 Evening ❌ 🌙 Night ❌

🍽️ Food Timing Guide

No specific food restrictions
Maintain a balanced diet
Good nutrition supports overall health during cancer treatment.

⏰ What to Do If You Miss a Dose

📌 You miss an appointment for your infusion
→ Contact your healthcare provider as soon as possible to reschedule.
💡 Do not try to self-administer or double the dose.
📌 You are unable to receive the infusion on the scheduled day
→ Your doctor will determine the best time to reschedule based on your treatment plan.
💡 Do not skip the dose entirely without medical advice.

⚠️ Side Effects of cyramza 500mg injection

✅ Common Side Effects

High blood pressure (Common (10-30%))
Monitor blood pressure regularly. Your doctor may prescribe blood pressure medicine if needed.
Diarrhea (Common (10-20%))
Stay hydrated and inform your doctor if it persists for more than 2 days.
Fatigue (Common (10-20%))
Rest when needed and avoid driving if you feel very tired.
Headache (Common (5-15%))
Take paracetamol if approved by your doctor. Report severe headaches immediately.
Low white blood cell count (Common (5-15%))
Your doctor will monitor blood counts. Report any fever or signs of infection.

🚨 Serious Side Effects

Severe bleeding (Uncommon (1-5%))
Seek immediate medical attention if you notice blood in vomit, black stools, or severe nosebleeds.
Blood clots (arterial thromboembolic events) (Uncommon (1-5%))
Call emergency services if you experience chest pain, sudden weakness, or difficulty speaking.
Gastrointestinal perforation (Rare (<1%))
Go to the emergency room if you have severe abdominal pain, fever, or vomiting.
Posterior reversible encephalopathy syndrome (PRES) (Rare (<1%))
Seek immediate medical attention if you have seizures, confusion, or vision changes.
Infusion-related reactions (Uncommon (1-5%))
Tell your nurse or doctor immediately if you feel chills, fever, rash, or difficulty breathing during the infusion.

⚠️ Rare Side Effects

Heart failure
Report swelling in legs, shortness of breath, or rapid weight gain to your doctor.
Thyroid dysfunction
Your doctor may check thyroid function if you experience fatigue or weight changes.
Nephrotic syndrome
Report swelling around eyes or in legs, or foamy urine, to your doctor.

Consult your doctor if you experience any unusual symptoms.

🔬 Drug Interactions

Drug Severity Effect
Warfarin Major
Heparin Major
Aspirin Major
Clopidogrel Major
Ibuprofen Major
Naproxen Major
Live vaccines Moderate
CYP3A4 inhibitors Minor
CYP3A4 inducers Minor
Paclitaxel Moderate

🚨 Major Interactions

  • Anticoagulants (e.g., warfarin, heparin)
  • Antiplatelet agents (e.g., aspirin, clopidogrel)
  • NSAIDs

⚡ Moderate Interactions

  • CYP3A4 inhibitors
  • Vaccines (live)

🍷 Alcohol Interaction

Alcohol may increase the risk of liver problems and bleeding. It is advisable to avoid alcohol while receiving this medicine.

🔎 Check Your Other Medicines

Educational tool. Always confirm with your doctor or pharmacist.

🛡️ Safety & Warnings

🚫 Contraindications

["Severe hypersensitivity to ramucirumab or any excipient","Active severe bleeding","Recent history of arterial thromboembolic events","Pregnancy"]

⚠️ Warnings & Precautions

["Hypertension: Monitor and control blood pressure before starting and during treatment.","Infusion-related reactions: Premedicate as needed and monitor during infusion.","Hemorrhage: Increased risk of bleeding; monitor for signs.","Arterial thromboembolic events: Discontinue if serious event occurs.","Gastrointestinal perforation: Discontinue if suspected.","Wound healing complications: Avoid use before and after surgery.","Posterior reversible encephalopathy syndrome: Discontinue if suspected.","Proteinuria: Monitor urine protein; discontinue if nephrotic syndrome develops."]

🤱 Lactation Safety

It is not known whether this medicine is present in human milk. Because of the potential for serious adverse reactions in breastfed infants, breastfeeding is not recommended during treatment and for at least 2 months after the last dose.

💊 Overdose Management

There is no specific antidote for overdose with this medicine. In case of overdose, treatment should be symptomatic and supportive. Monitor vital signs and provide appropriate care.

⏰ Missed Dose

If a dose is missed, contact your healthcare provider to reschedule. Do not double the dose to catch up.

Additional Safety Advice

General Safety

This medicine must only be given by a qualified healthcare professional in a clinical setting equipped to manage infusion reactions. Patients should have their blood pressure checked before each infusion and monitored regularly during treatment. Women of childbearing age should use effective contraception during treatment and for at least three months after the last dose. This medicine can cause harm to a developing fetus, so pregnancy should be avoided. Breastfeeding is not recommended during treatment and for at least two months after the last dose. Patients should inform their doctor about all other medicines, especially blood thinners, before starting this treatment. Any signs of bleeding, such as blood in vomit, black stools, or unusual bruising, should be reported immediately. Do not drive or operate heavy machinery if you feel dizzy or fatigued after the infusion.

👴 Special Considerations for Elderly

💡 For Patients Above 65

Elderly patients may be more susceptible to side effects such as hypertension, bleeding, and thromboembolic events. Close monitoring is recommended. No dose adjustment is required based on age alone.

🤰 Pregnancy Planning (TTC)

This medicine can harm a developing fetus. Women of childbearing age should use effective contraception during treatment and for at least 3 months after the last dose. If you are planning pregnancy, discuss with your doctor before starting treatment.

🏥 Post-Surgery Considerations

This medicine may impair wound healing and increase bleeding risk. It should be stopped at least 4 weeks before scheduled surgery. Discuss with your surgeon and oncologist.

🦷 Dental Procedures

Inform your dentist that you are receiving this medicine. It may increase bleeding risk during dental procedures. Your dentist may recommend postponing non-urgent procedures.

💚 Lifestyle Tips for Better Results

🏃
Maintain a healthy diet rich in fruits, vegetables, and lean protein.
🥗
Stay physically active as tolerated to reduce fatigue.
😴
Monitor your blood pressure at home if advised.
💧
Avoid smoking and limit alcohol consumption.
🧘
Get adequate rest and manage stress through relaxation techniques.
🌞
Keep all follow-up appointments for monitoring.

🏋️ Exercise Considerations

Exercise as tolerated, but avoid strenuous activities that could increase bleeding risk. Consult your doctor before starting any new exercise program.

🥗 Diet Recommendations

Eat small, frequent meals if you have nausea.
Stay well hydrated by drinking plenty of fluids.
Include protein-rich foods to support healing.
Avoid raw or undercooked foods to prevent infections.
Limit high-sodium foods to help control blood pressure.

💼 Impact on Daily Work & Life

This medicine may cause fatigue, dizziness, or high blood pressure, which can affect your ability to work or drive. Avoid driving or operating heavy machinery if you feel unwell. Discuss work accommodations with your employer if needed.

🛑 When to Stop This Medicine

Do not stop this medicine without consulting your doctor. Treatment may be stopped if serious side effects occur, such as severe bleeding, thromboembolic events, or uncontrolled hypertension. Your doctor will decide if and when to discontinue.

📅 Long-Term Use Effects

Long-term use of this medicine may lead to persistent hypertension, proteinuria, and increased risk of bleeding or clotting. Regular monitoring of blood pressure, urine protein, and blood counts is necessary. Some patients may experience chronic fatigue. The risk of these effects increases with duration of treatment. Your doctor will assess the benefit-risk balance periodically.

🌿 Non-Medicine Approaches

These can complement medicine but do not replace prescribed treatment.

Other anti-angiogenic agents

Bevacizumab or aflibercept may be alternatives in some cancers.

Evidence: Well-established
Clinical trials

Enrollment in clinical trials may offer access to new treatments.

Evidence: Varies

💉 Vaccination Considerations

💉 If You're Getting Vaccinated

Live vaccines should be avoided during treatment with this medicine due to the risk of infection. Inactivated vaccines may be given, but the immune response may be reduced. Consult your doctor before receiving any vaccine.

📦 Storage Guide

✅ DO

Store in a refrigerator at 2°C to 8°C

❌ DON'T

Do not freeze

✅ DO

Keep vials in the original carton to protect from light

❌ DON'T

Do not remove from carton until ready to use

✅ DO

Do not shake the vial

❌ DON'T

Do not use if the solution is discolored or contains particles

✈️ Traveling with This Medicine

When traveling, carry this medicine in its original packaging with a copy of your prescription. It must be stored in a refrigerator at 2°C to 8°C. If traveling by air, carry it in hand luggage with a doctor&#039;s letter. Plan infusions around your travel schedule. Inform airport security about the medication and any needles or medical devices.

💰 Cost Analysis & Savings

👥 Real Patient Stories

Educational, anonymized scenarios. Individual results may vary.

👤 A 62-year-old man with advanced gastric cancer
He received this medicine along with paclitaxel every two weeks. After three cycles, his tumor size decreased, and his symptoms improved. He experienced mild fatigue and high blood pressure, which were managed with medication. He emphasized the importance of regular blood pressure checks.
💡 Lesson: Regular monitoring and prompt management of side effects can help patients continue treatment and achieve better outcomes.
👤 A 55-year-old woman with metastatic colorectal cancer
She was started on this medicine with FOLFIRI after her cancer progressed on prior therapy. She developed proteinuria, which was detected early through routine urine tests. Her dose was temporarily held, and she recovered. She continued treatment with close monitoring.
💡 Lesson: Routine urine protein monitoring is essential to detect and manage kidney-related side effects early.

💬 Questions Patients Often Ask

Q: How long does it take to work?

A: The effects of this medicine are not immediate. It may take several weeks to months to see benefits, such as slowed tumor growth. Your doctor will monitor your response with regular scans.

Q: How is this medicine given?

A: This medicine is given as an intravenous infusion by a healthcare professional, usually over 60 minutes.

Q: What should I avoid while on this medicine?

A: Avoid alcohol, live vaccines, and activities that increase bleeding risk. Inform your doctor about all other medicines you take.

🤔 Common Patient Concerns

💭 These are the concerns patients most commonly raise

  • Can I take this medicine if I have high blood pressure?
  • Will this medicine affect my kidney function?
  • Can I drive after receiving this medicine?
  • Does this medicine interact with blood thinners?
  • What if I miss an infusion?
  • Can I drink alcohol while on this medicine?

🛑 Myths vs. Facts

  • Myth: This medicine can cure cancer completely.
    Fact: This medicine is not a cure. It helps control tumor growth and may extend survival when used with other treatments.
  • Myth: This medicine can be taken at home.
    Fact: This medicine must be given by a healthcare professional in a clinical setting.
  • Myth: This medicine has no side effects.
    Fact: This medicine can cause side effects, some of which can be serious. Regular monitoring is required.

🔄 Alternative Options

Brand Alternatives

📊 Comparison with Similar Medicines

MedicineClassRoutePrimary Use
RamucirumabVEGFR-2 antagonistIntravenousGastric, colorectal, liver, lung cancers
BevacizumabVEGF inhibitorIntravenousColorectal, lung, kidney, cervical cancers

😊 Was this information helpful?

Browse Medicines A-Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Back to Medicines Directory